Onyx Bridge Wealth Group LLC Recursion Pharmaceuticals, Inc. Transaction History
Onyx Bridge Wealth Group LLC
- $684 Million
- Q2 2025
A detailed history of Onyx Bridge Wealth Group LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Onyx Bridge Wealth Group LLC holds 11,500 shares of RXRX stock, worth $63,020. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,500Holding current value
$63,020% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
356Shares Held
283MCall Options Held
3.29MPut Options Held
3.24M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$181 Million1.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$177 Million0.0% of portfolio
-
Baillie Gifford & CO24.2MShares$132 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$94.9 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$80.4 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $989M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...